Picture of Imugene logo

IMU Imugene Cashflow Statement

0.000.00%
au flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Annual cashflow statement for Imugene, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

2020
June 30th
2021
June 30th
2022
June 30th
2023
June 30th
2024
June 30th
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Changes in Working Capital4.134.826.5412.60
Other Operating Cash Flow
Cash from Operating Activities-10.4-13.3-30.8-31.5-102
Capital Expenditures-1.49-5.45-0.258-9.46
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items0.280.1210.0371.72.2
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-1.21-5.33-0.2211.7-7.25
Financing Cash Flow Items-1.81-0.131-7.53-5.04-2.74
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities22.7181018349.4
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash11.1-0.6270.453.3-60